Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b]difuran-4-yl)-2-aminopropane; ‘ B-fly’). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon. © 2011 Bentham Science Publishers Ltd.

Designer Drugs on the Internet: a Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly / Flesland, Liv; Scherbaum, Norbert; Van Der Kreeft, Peer; Pezzolesi, Cinzia; Skutle, Arvid; Siemann, Holger; Shapiro, Harry; Pisarska, Agnieszka; Moskalewicz, Jacek; Mervo, Barbara; Corazza, Ornella; Di Furia, Lucia; Demetrovics, Zsolt; Torrens, Marta; Drummond, Colin; Davey, Zoe; Deluca, Paolo; Farre, Magi; Schifano, Fabrizio. - In: CURRENT CLINICAL PHARMACOLOGY. - ISSN 1574-8847. - 6:2(2011), pp. 125-129. [10.2174/157488411796151129]

Designer Drugs on the Internet: a Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly

Ornella Corazza;
2011-01-01

Abstract

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon. © 2011 Bentham Science Publishers Ltd.
2011
2
Flesland, Liv; Scherbaum, Norbert; Van Der Kreeft, Peer; Pezzolesi, Cinzia; Skutle, Arvid; Siemann, Holger; Shapiro, Harry; Pisarska, Agnieszka; Moska...espandi
Designer Drugs on the Internet: a Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly / Flesland, Liv; Scherbaum, Norbert; Van Der Kreeft, Peer; Pezzolesi, Cinzia; Skutle, Arvid; Siemann, Holger; Shapiro, Harry; Pisarska, Agnieszka; Moskalewicz, Jacek; Mervo, Barbara; Corazza, Ornella; Di Furia, Lucia; Demetrovics, Zsolt; Torrens, Marta; Drummond, Colin; Davey, Zoe; Deluca, Paolo; Farre, Magi; Schifano, Fabrizio. - In: CURRENT CLINICAL PHARMACOLOGY. - ISSN 1574-8847. - 6:2(2011), pp. 125-129. [10.2174/157488411796151129]
File in questo prodotto:
File Dimensione Formato  
Corazza et al B-Fly170311.pdf

accesso aperto

Tipologia: Post-print referato (Refereed author’s manuscript)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 195.94 kB
Formato Adobe PDF
195.94 kB Adobe PDF Visualizza/Apri
Corazza_etal_2011_CCP_Bromo-Dragonfly-2-6.pdf

Solo gestori archivio

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 100.08 kB
Formato Adobe PDF
100.08 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/372068
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 72
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex 98
social impact